Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact
October 24, 2012
Strategic Alliance Partnerships: Development of a Successful FSP Relationship
Speakers for this Event:
  • Andrew S. Townshend, Vice President of Alliance Development, INC Research   Learn More
  • Peter Carberry, Senior VP, Global Development Operations, Astellas Pharma Global
        Development Inc.
     Learn More

    Financial and competitive pressures in Research and Development for the biopharmaceutical industry are challenging the traditional, often narrowly focused transactional relationships with CROs and driving an evolution in outsourcing partnerships. These new and innovative partnership models are focused upon true partnership, innovation, optimization of oversight and ultimately increased speed and reduced cost.

    One of the most effective partnership models and one that continues to play a prominent role in the industry is a Functional Service Provider relationship.

    In this webinar Dr. Peter Carberry, Senior Vice President Development Operations at Astellas and Andrew Townshend, Vice President Alliance Development at INC Research will discuss how to develop and implement a true partnership through an FSP outsourcing model – characterized by long term goals, integration of operations and leadership and optimized delivery based on portfolio transparency, dedicated resourcing, INC’s Trusted Process and innovation in process and technology.

    The webinar will also address the challenges for both a sponsor and a CRO in evolving to a new and often more complex but successful outsourcing relationship.


    Pharmaceutical and biotech product development and strategy professionals, research and development professionals and other professionals involved in drug development and clinical trials outsourcing


    Andrew S. Townshend, Vice President of Alliance Development, INC Research

    Andrew Townshend is Vice President of Alliance Development at INC Research. Mr. Townshend is responsible for developing strategic accounts within the Pharma and biotech industries. This includes a responsibility for the top 20 pharma companies and focuses on novel and innovative engagement and alliance models.

    Prior to this, Mr. Townshend was the Vice President and Worldwide Head of Outsourcing for Pfizer in New York. In this role, he was responsible for all development contracting and budgeting including clinical trial related and investigator-initiated research contracts.

    Mr. Townshend has held a number of positions in outsourcing for Research & Development and Commercial Divisions in Pfizer both in the UK and US. Earlier, Mr. Townshend has spent over five years in various Business Development roles at Covance.

    Peter Carberry, Senior VP, Global Development Operations, Astellas Pharma Global Development Inc.

    Dr. Carberry is responsible for enhancing the effectiveness and efficiency of the integrated global operational platform including the data sciences and clinical operations organizations.

    Prior to joining Astellas, Dr. Carberry was the vice president of clinical operations, development planning and performance analysis and the office of international development at Genentech. In that role, Dr. Carberry developed a global platform for the execution of non-clinical and clinical activities and established many key relationships with company stakeholders.

    Previously, Dr. Carberry was the senior vice president of global clinical operations at Johnson & Johnson Pharmaceutical Research and Development. Dr. Carberry began his industry career with Pharmacia at the Kalamazoo Research site where he held positions of increasing responsibility across the development organization.

    Dr. Carberry earned his M.D. at the University of Nairobi in Kenya and completed his Post Doctoral Fellowship in Clinical Pharmacology at the University of Texas. He earned his M.B.A. at Western Michigan University.


    INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women's health trials. The company's The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit www.incresearch.com

    For information about the recorded archive for this event contact Xtalks at (416) 977-6555 ext 371, or email register@xtalks.com

    Copyright © 2016-2017 Honeycomb Worldwide Inc.